Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Levine
    Levine
  2. Arcila
    Arcila
  3. Park
    Park
  4. Scheinberg
    Scheinberg
  5. Nafa
    Nafa
  6. Stein
    Stein
  7. Yao
    Yao
  8. Dogan
    Dogan
  9. Mauro
    Mauro
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Adult Leukemia (67)
  2. Center for Hematologic Malignancies (67)
  3. Department of Medicine (67)
  4. Hematologic Malignancies, Division of (67)
  5. GSK Faculty (28)
  6. Executive Committee, Center for Hematologic Malignancies (17)
  7. Center for Molecular Imaging and Biotechnology (14)
  8. Tow Center for Developmental Oncology (TCDO) (14)
  9. Human Oncology and Pathogenesis Program (13)
  10. Department of Pathology and Laboratory Medicine (12)
Search Within
  1. "Adult Leukemia"
Formats
  1. Meeting Abstract (32)
  2. Journal Article (29)
  3. Review (5)
  4. Editorial (1)
Groups
  1. Adult Leukemia (67)
  2. Center for Hematologic Malignancies (67)
  3. Department of Medicine (67)
  4. Hematologic Malignancies, Division of (67)
  5. GSK Faculty (28)
  6. Executive Committee, Center for Hematologic Malignancies (17)

More Groups

People
  1. Ross Levine (12)
  2. Eytan Stein (10)
  3. Maria Arcila (10)
  4. Jae Park (9)
  5. David Scheinberg (8)
  6. Anthony Mato (7)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (5)
  4. 2022 (4)
  5. 2021 (5)
  6. 2020 (6)

More Years

Publications
  1. Experimental Hematology (15)
  2. Value in Health (13)
  3. Journal of Molecular Diagnostics (12)
  4. The Lancet Haematology (7)
  5. Biochemical and Biophysical Research Communications (4)
  6. Lancet (4)

More Publications

Results (67)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: A phase 1, first-in-human trial
    Journal Article

    Ghobadi, A.; Bachanova, V.; Patel, K.; Park, J. H.; Flinn, I.; Riedell, P. A.; Bachier, C.; Diefenbach, C. S.; Wong, C.; Bickers, C.; more...
    Lancet (2025)

    Fulltext@MSK | Save
  • OncoKB: Automated somatic variant classification for rapid clinical decision making
    Meeting Abstract

    Suehnholz, S.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Cavender, K.; Preiser, B.; Konecny, J.; more...
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia
    Review

    Aldoss, I.; Roboz, G. J.; Bassan, R.; Boissel, N.; DeAngelo, D. J.; Fleming, S.; Gökbuget, N.; Logan, A. C.; Luger, S. M.; Menne, T.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Production of alarmins S100a8/A9 by DNMT3A-mutant hematopoietic cells causes mesenchymal stromal cell senescence and seeds a pro-inflammatory environment in clonal hematopoiesis
    Meeting Abstract

    Mistry, J.; Young, K.; Maestre, I. F.; Levine, R.; Trowbridge, J.
    Experimental Hematology (2024)

    Fulltext@MSK | Save
  • Genomic evolution of philadelphia negative myeloproliferative neoplasms with double driver mutations
    Meeting Abstract

    Sardana, R.; Boiocchi, L.; Yao, J.; Lee, D.; Rampal, R. K.; Arcila, M.; Ewalt, M.
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Targeting JAK1 signaling for molecular prevention in clonal hematopoiesis
    Meeting Abstract

    Vela, P. S.; Wang, R.; Tran, D.; Benitez, A. M.; Krishnan, A.; O'Connor, K.; Liu, W.; Kleppe, M.; Bowman, R.; Cai, S.; more...
    Experimental Hematology (2023)

    Fulltext@MSK | Save
  • Validation of a high-sensitivity assay for detection of chimeric antigen receptor T-cell vectors using low-partition digital PCR technology
    Journal Article

    Arcila, M. E.; Patel, U.; Momeni-Boroujeni, A.; Yao, J.; Chan, R.; Chan, J.; Rijo, I.; Yu, W.; Chaves, N.; Patel, H.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Clonal characterization and somatic hypermutation assessment by next-generation sequencing in chronic lymphocytic leukemia/small lymphocytic lymphoma: A detailed description of the technical performance, clinical utility, and platform comparison
    Journal Article

    Petrova-Drus, K.; Syed, M.; Yu, W.; Hutt, K.; Zlotnicki, A. M.; Huang, Y.; Kamalska-Cyganik, M.; Maciag, L.; Wang, M.; Ma, Y. G.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: A phase 1, dose-finding and expansion study
    Journal Article

    Garcia-Manero, G.; Goldberg, A. D.; Winer, E. S.; Altman, J. K.; Fathi, A. T.; Odenike, O.; Roboz, G. J.; Sweet, K.; Miller, C.; Wennborg, A.; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save
  • Health care resource utilization with asciminib and bosutinib among adults with chronic myeloid leukemia in chronic phase previously treated with ≥2 tyrosine kinase inhibitors: Week 48 and week 96 results from ASCEMBL trial
    Meeting Abstract

    Cortes, J. E.; Sasaki, K.; Réa, D.; Mauro, M. J.; Tran, D.; Wang, P.; Jadhav, K.; Di Caprio, L.; Yocolly, A.
    Value in Health (2022)

    Fulltext@MSK | Save